Differential impact of milvexian, an investigational oral FXIa inhibitor vs apixaban and dabigatran on thrombin generation in human donor plasma in vitro
Authors: M Bunce, M Chintala
Published: 2022-10-15
DOI:
10.1093/eurheartj/ehac544.3068
Source:
Full article
Abstract
Abstract